AZBio In the Loop – BIO Week Edition – Week of June 4, 2018

 


 

AZBio Members are heading to Boston

 this week for BIO 2018 & RESI 

The BIO International Convention is the biggest industry event of the year.  

Click here to learn more.

See what we’re sharing in Boston this week.

AZBio Member News

 

Helios Scholars at TGen prepares students for success in college and career

45 summer interns join TGen scientists in real-life biomedical research

Castle Biosciences Launches Next-Generation Sequencing Test DecisionDx-CMSeq for Cutaneous Melanoma

New test complements Castle’s DecisionDx-Melanoma gene expression profile test

Amgen Foundation And Harvard Team Up To Offer Free Online Science Education Platform

LabXchange Will Provide Virtual Lab Experiences Integrating Digital Instruction With Collaboration and Mentoring Opportunities.  Interactive Platform Levels Playing Field for Aspiring Scientists.  Amgen Foundation Contributes $6.5 Million as Founding Sponsor

TGen and Huntsman Cancer Institute receive $6.7 million grant to battle a hidden enemy

Department of Defense grant aims to target breast cancer that has spread to the bone by re-igniting the body’s own immune system.

Startup Licenses UA Invention to Enhance Natural Safeguard Against Skin Cancer and Other Diseases

The University of Arizona has licensed two inventions developed in the Department of Chemistry and Biochemistry to startup MCR Therapeutics. The inventors – Drs. Minying Cai and Victor J. Hruby – developed targeted peptides through their research into drug design and bioactivity expression relating to hormone activity in the brain and periphery.

For improving scientific reproducibility, biological samples are key

From humble roots in antiquity, the scientific method has come to dominate and transform modern society. Our insights into the natural world, from bacteria to black holes, are fruits of the scientific approach to understanding, as are the life-saving medical innovations society relies on.

TGen-Barrow study shows drug penetration of glioblastoma

Innovative ‘Phase 0’ clinical trial successful in reaching deadly brain tumors

All of Us Research Program Begins National Enrollment Effort; Nine Banner Sites in Arizona Enrolling Volunteers

Events are planned across the nation to engage diverse communities in the national recruitment effort. In Arizona, Banner Health and the University of Arizona Health Sciences have been enrolling volunteers into the program as a National Institutes of Health pilot site since 2017.

Salutaris Medical Devices, Inc. announces first subject treated in a clinical trial investigating the SMD-DA ophthalmic device for the treatment of neovascular Age-related Macular Degeneration (nAMD)

Salutaris Medical Devices, Inc.  announced the first subject was treated in a multi-center clinical trial investigating the use of its ophthalmic brachytherapy device to treat neovascular Age-related Macular Degeneration (nAMD) on May 23, 2018.

Opportunity Alerts

   

Looking for Investors?  Applications are open for White Hat 2018

Application Deadline is July 1st.
All applicants will know their status by August 1st.

Tell us who inspires you…

Nominations are open for the 2018 AZBio Awards.  Learn More 
Nominations close July 1st. 
Applications are now open for the Student Discovery Zone.  Learn More

Post your open career opportunities today at  Jobs.AZBio.org

Who’s Hiring? Click here to find out.  

“Connecting Talent with Opportunity” takes on a new meaning with up to ten  FREE 30-day Standard Job Postings on the AZBio Career Center.

Learn More About the AZBio Talent Challenge – Summer 2018

Got a legal question?

Check out a new service for AZBio Members –  Office Hours at Perkins Coie

Do YOU have news to share with our community?  

Send your news and events to JKW@AZBio.org

(For better formatting, please do not send PDF’s.)

Events  – Committees – Savings

Get Connected – Sign up today!

 

Click Here to View the  FINAL RESULTS of the 
2018 AZBio Legislative Watch List

Save the date: AZBio Government Affairs Call: 

Thursday, Sept. 13th at 3 PM 

All AZBio Members are welcome to join the AZBio Government Affairs Committee. 

 Click here to be added to the committee  

 Click here to download our 2018 Plans

SAVINGS:

 AZBio Purchasing Power

 

AZBio Members saved over $3 Million via AZBio Purchasing Power in 2017. 

 Click here to learn more how YOU can save on these product and services. 

  

Join  AZBio

AZBio is committed to making
Arizona a Top Tier Bioscience State. 
AZBio Members are making it happen!View AZBio Member Directory
To learn more about AZBio click here     

 Thank you to our AZBio Supporters


Legacy Level:  Arizona Commerce Authority 
                          BIO *  Dorn Policy Group  
Chairman’s Circle:    BusinessWire  * City of Phoenix * Flinn Foundation  *  Roche 
Leadership Level: Alliant Insurance * Amgen * Arizona Science Center *Bard Peripheral Vascular  * City of Scottsdale *  City of Tempe  *  Cord Blood Registry (CBR) * Dignity Health * Genentech  * Janssen Biotech * KCA * Medtronic Tempe Campus * New Angle Media *   Novartis  *  Pfizer *  PhRMA *  Roche Diagnostics *  TGen * The Biodesign Institute at ASU * UA BIO5 * Ulthera * University of Arizona * Ventana Medical Systems * VWR   
Sustaining Partners:  AdvaMed  *  Affordable Image * Alliance Bank of Arizona *  Allergan  *  APS * Bank of America * Bristol-Myers Squibb *  EY * International Research Center * Merrill Lynch * Midwestern University * NFP *  PADT Medical * Perkins Coie * Pinnacle Transplant Technologies  *  Snell & Wilmer * U.S. Trust  

AZBio Supporters make what we do possible.


 Download the 2018 AZBio Prospectus to learn more.

Copyright © 2018 AZBio. All rights reserved.
Arizona BioIndustry Association, Inc.
1

 

Posted in AZBio News, In the Loop.